Acute chest pain remains one of the most common and challenging symptoms encountered in clinical practice. It is crucial to promptly and accurately diagnose the underlying cause, as the range of potential etiologies includes life-threatening conditions.
The initial approach should involve a thorough history and physical examination. Key historical elements include the nature, location, and duration of the pain, associated symptoms, and risk factors for coronary artery disease. The physical examination should aim to identify signs of cardiopulmonary disease or other potential causes of chest pain.
Electrocardiography (ECG) is the first-line diagnostic test for patients presenting with acute chest pain. Subsequent testing should be guided by the clinical suspicion for specific conditions. High-risk patients may warrant immediate invasive strategies, while low-risk patients may undergo further non-invasive testing.
Imaging modalities such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) can provide additional diagnostic information. For instance, CT coronary angiography can be useful in ruling out coronary artery disease in low to intermediate risk patients.
The management of acute chest pain should be tailored to the underlying cause. In cases of acute coronary syndrome, immediate reperfusion therapy is indicated. Other conditions may require medical management, surgical intervention, or observation depending on the specific diagnosis.
Acute chest pain is a complex clinical challenge requiring a comprehensive and systematic approach. A thorough history and physical examination, coupled with judicious use of diagnostic testing, can facilitate accurate diagnosis and appropriate management. Continued research and advancements in diagnostic modalities promise to further enhance our ability to evaluate and manage this common clinical conundrum.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation